Analyst Reco. QuidelOrtho Corporation

Stocks

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-08 pm EDT			5-day change	1st Jan Change
14.46 ^USD	+0.94%		+9.01%	-49.35%

May. 07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
May. 07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT

Analyst Reco.

May. 07	UBS Adjusts Price Target on QuidelOrtho to $12 From $17, Maintains Neutral Rating	MT
May. 07	Jefferies Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $12.50 From $35	MT
Apr. 10	UBS Adjusts Price Target on QuidelOrtho to $17 From $30, Maintains Neutral Rating	MT
Feb. 12	UBS Adjusts QuidelOrtho Price Target to $30 From $35, Maintains Neutral Rating	MT
Jan. 21	UBS Adjusts QuidelOrtho Price Target to $35 From $31, Maintains Neutral Rating	MT
Nov. 06	UBS Adjusts Price Target on QuidelOrtho to $31 From $26, Maintains Neutral Rating	MT
Nov. 03	QuidelOrtho Receives FDA 510(k) Clearance for VITROS?? Immunodiagnostic Products hs Troponin I Assay	CI
Nov. 03	Quidelortho receives FDA 510(k) clearance for VITROS Immunodiagnostic Products hs Troponin I assay	RE
25-10-07	Citigroup Downgrades QuidelOrtho to Neutral From Buy, Adjusts Price Target to $33 From $40	MT
25-09-03	RBC Raises Price Target on QuidelOrtho to $62 From $60, Keeps Outperform Rating	MT
25-08-07	UBS Cuts Price Target on QuidelOrtho to $26 From $29, Maintains Neutral Rating	MT
25-05-08	UBS Cuts Price Target on QuidelOrtho to $29 From $45, Keeps Neutral Rating	MT
25-02-13	UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating	MT
25-02-13	RBC Trims Price Target on QuidelOrtho to $61 From $64, Keeps Outperform Rating	MT
24-12-11	Citigroup Upgrades QuidelOrtho to Buy From Neutral, Raises Price Target to $50 From $44	MT
24-12-10	Jefferies Initiates QuidelOrtho at Hold With $43 Price Target	MT
24-11-08	UBS Cuts Price Target on QuidelOrtho to $43 From $50, Maintains Neutral Rating	MT
24-11-08	RBC Capital Adjusts QuidelOrtho Price Target to $64 From $62, Maintains Outperform Rating	MT
24-09-19	UBS Upgrades QuidelOrtho to Neutral From Sell, Adjusts Price Target to $50 From $42	MT
24-09-13	RBC Lifts Price Target on QuidelOrtho to $62 From $61, Keeps Outperform Rating	MT
24-09-05	QuidelOrtho Shares Rise After Craig-Hallum Upgrade	MT
24-09-05	Craig-Hallum Upgrades QuidelOrtho to Buy From Hold, Adjusts Price Target to $57 From $40	MT
24-06-24	RBC Cuts Price Target on QuidelOrtho to $61 From $68, Keeps Outperform Rating	MT
24-05-09	RBC Cuts Price Target on QuidelOrtho to $68 From $81, Keeps Outperform Rating	MT
24-03-04	UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	MT